These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23271894)

  • 21. Application of antidepressants in depression: A systematic review and meta-analysis.
    Yuan Z; Chen Z; Xue M; Zhang J; Leng L
    J Clin Neurosci; 2020 Oct; 80():169-181. PubMed ID: 33099342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder.
    Sinha S; Chary S; Thakur P; Talluri L; Reddy M; Verma KK; Saha P; Gupta VB; Ramaiah KA; Khanum SZ
    Cureus; 2021 Jul; 13(7):e16689. PubMed ID: 34513348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
    Wohlreich MM; Martinez JM; Mallinckrodt CH; Prakash A; Watkin JG; Fava M
    J Clin Psychopharmacol; 2005 Dec; 25(6):552-60. PubMed ID: 16282837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escitalopram: a review of its use in the management of anxiety disorders.
    Dhillon S; Scott LJ; Plosker GL
    CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.
    Signorovitch J; Ramakrishnan K; Ben-Hamadi R; Yu AP; Wu EQ; Dworak H; Erder MH
    Curr Med Res Opin; 2011 Jun; 27(6):1089-96. PubMed ID: 21438794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study.
    Woo YS; McIntyre RS; Kim JB; Lee MS; Kim JM; Yim HW; Jun TY
    Clin Psychopharmacol Neurosci; 2017 Nov; 15(4):391-401. PubMed ID: 29073751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiety symptom remission is associated with genetic variation of PTPRZ1 among patients with major depressive disorder treated with escitalopram.
    Su YA; Bousman CA; Liu Q; Lv XZ; Li JT; Lin JY; Yu X; Tian L; Si TM
    Pharmacogenet Genomics; 2021 Oct; 31(8):172-176. PubMed ID: 34081644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.
    Bose A; Tsai J; Li D
    Clin Drug Investig; 2012 Jun; 32(6):373-85. PubMed ID: 22559255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of escitalopram and severity of depression: new data].
    Spadone C
    Encephale; 2009 Dec; 35(6):577-85. PubMed ID: 20004289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Escitalopram therapy for major depression and anxiety disorders.
    Baldwin DS; Reines EH; Guiton C; Weiller E
    Ann Pharmacother; 2007 Oct; 41(10):1583-92. PubMed ID: 17848424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of escitalopram and citalopram efficacy: A meta-analysis.
    Auquier P; Robitail S; Llorca PM; Rive B
    Int J Psychiatry Clin Pract; 2003; 7(4):259-68. PubMed ID: 24930412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial.
    Kishi T; Matsuda Y; Matsunaga S; Moriwaki M; Otake Y; Akamatsu K; Okochi T; Hirano S; Funahashi T; Okuda M; Tabuse H; Fujita K; Iwata N
    Neuropsychiatr Dis Treat; 2017; 13():117-125. PubMed ID: 28123299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escitalopram for the treatment of major depression and anxiety disorders.
    Höschl C; Svestka J
    Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escitalopram in major depressive disorder: clinical benefits and cost effectiveness versus citalopram.
    Lançon C; Verpillat P; Annemans L; Despiegel N; François C
    Int J Psychiatry Clin Pract; 2007; 11(1):44-52. PubMed ID: 24941275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duloxetine: a review of its use in the treatment of major depressive disorder.
    Frampton JE; Plosker GL
    CNS Drugs; 2007; 21(7):581-609. PubMed ID: 17579500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review.
    Maneeton B; Maneeton N; Likhitsathian S; Woottiluk P; Wiriyacosol P; Boonyanaruthee V; Srisurapanont M
    Neuropsychiatr Dis Treat; 2018; 14():1953-1961. PubMed ID: 30122927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.